Curexo, a manufacturer of a surgical system using robots, announced Sunday that it has appointed Mun In-ki as the new president and CEO of its American subsidiary company, CTC.

Mun previously served as vice president for research technology at the Hospital Corp. of America, or HCA.

Mun holds a Ph.D. from Cornell University and worked at the Miami Heart Institute (now known as the Florida Heart Institute) and the Aventura Hospital and Medical Center in Aventura, Florida, among others.

According to company officials, Mun has been involved in research development for medical devices, medical systems and related fields over the years.

CTC, also known as Curexo Technology Corp., is a Fremont, California-based subsidiary of Curexo, Inc. As the original producer and developer of the robotic system, which assists in surgical procedures, CTC owns the patent for the device.

(renee@heraldcorp.com)